Oorsprong van het eerstegraads netwerk van Ben Sattelle
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ben Sattelle via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Founder Founder | |
| University of Oxford | College/University | Doctorate Degree | |
| The University of Edinburgh | College/University | Undergraduate Degree | |
| The University of Manchester | College/University | Doctorate Degree | |
Imperagen Ltd.
 Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 5 |
| Israël | 2 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Commercial Services | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 4 |
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
| President | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Andrew Almond | 5 |
| Charles Douglas Blundell | 3 |
- Beurs
- Insiders
- Ben Sattelle
- Bedrijfsconnecties
